Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome.
Chatelet
V
V
Frémeaux-Bacchi
V
V
Lobbedez
T
T
Ficheux
M
M
Hurault de Ligny
B
B
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage* / Q000009:adverse effects; D016030:Kidney Transplantation; D012008:Recurrence
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; C481642:eculizumab